St. Vincenz Krankenhaus GmbH
Paderborn, Germany
General hospital in Paderborn, North Rhine-Westphalia
Am Busdorf 2, 33098 Paderborn
About St. Vincenz Krankenhaus GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Biotronik SE & Co. KG
4
Hoffmann-La Roche
4
Boehringer Ingelheim
2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
2
Daiichi Sankyo, Inc.
2
Medtronic Cardiac Rhythm and Heart Failure
2
Pfizer
2
AGO Research GmbH
1
CVRx, Inc.
1
Correvio International Sarl
1
Institut für Klinisch-Kardiovaskuläre Forschung GmbH
1
Clinical Trials at St. Vincenz Krankenhaus GmbH
During the past decade, St. Vincenz Krankenhaus GmbH conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Closed Loop Stimulation, Cognitive Performance, and Quality of Life in Pacemaker Patients
2006-05-01
2011-03-01
Completed
405
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer
2006-07-01
2016-06-01
Completed
1,256
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
2006-12-01
2011-06-01
Terminated
888
Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia
2004-10-01
2008-04-01
Completed
516
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
2006-04-01
Completed
1,520
Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function
2007-07-01
2013-08-01
Completed
720
Survival of Patients With Primary Prophylactic ICD Indication
2008-02-01
2014-07-01
Completed
504
Catheter Ablation vs. Standard Conventional Treatment in Patients With LV Dysfunction and AF
2008-01-01
2017-03-01
Completed
398
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "St. Vincenz Krankenhaus GmbH" #1 sponsor was "Biotronik SE & Co. KG" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials
sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 2 trials sponsored and "Daiichi Sankyo, Inc."
with 2 trials sponsored. Other sponsors include 11 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Vincenz Krankenhaus GmbH"
#1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were
collaborators in the rest 19 trials.
Clinical Trials Conditions at St. Vincenz Krankenhaus GmbH
According to Clinical.Site data, the most researched conditions in "St. Vincenz Krankenhaus GmbH" are
"Atrial Fibrillation" (6 trials), "Breast Cancer" (3 trials), "Ovarian Cancer" (3 trials), "Heart Failure" (2 trials) and "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "St. Vincenz Krankenhaus GmbH" in a lesser frequency.
Clinical Trials Intervention Types at St. Vincenz Krankenhaus GmbH
Most popular intervention types in "St. Vincenz Krankenhaus GmbH" are "Drug" (16 trials), "Other" (5 trials), "Biological" (4 trials), "Device" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Edoxaban" (2 trials), "5-FU" (1 trials), "5-FU and oxaliplatin" (1 trials) and "Abagovomab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St. Vincenz Krankenhaus GmbH
The vast majority of trials in "St. Vincenz Krankenhaus GmbH" are
26 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at St. Vincenz Krankenhaus GmbH
Currently, there are NaN active trials in "St. Vincenz Krankenhaus GmbH".
undefined are not yet recruiting,
7 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in St. Vincenz Krankenhaus GmbH,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in St. Vincenz Krankenhaus GmbH, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 1 trials that are defined as “Not Applicable".